Fragasso Group Inc. Charles River Laboratories International, Inc. Transaction History
Fragasso Group Inc.
- $1.25 Billion
- Q4 2024
A detailed history of Fragasso Group Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fragasso Group Inc. holds 14,538 shares of CRL stock, worth $2.43 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
14,538
Previous 15,025
3.24%
Holding current value
$2.43 Million
Previous $2.96 Million
9.33%
% of portfolio
0.21%
Previous 0.24%
Shares
24 transactions
Others Institutions Holding CRL
# of Institutions
709Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$850 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$364 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$302 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$301 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.49B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...